These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 25925356

  • 1. FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours.
    Nakajo M, Jinguji M, Fukukura Y, Kajiya Y, Tani A, Nakajo M, Nakabeppu Y, Arimura H, Nishio Y, Nakamura F, Yoshiura T.
    Eur Radiol; 2015 Dec; 25(12):3696-705. PubMed ID: 25925356
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors.
    Nakajo M, Nakajo M, Fukukura Y, Jinguji M, Shindo T, Nakabeppu Y, Kamimura K, Yoneyama T, Takumi K, Yoshiura T.
    Abdom Imaging; 2015 Aug; 40(6):1655-65. PubMed ID: 25382022
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?
    Kunikowska J, Matyskiel R, Toutounchi S, Grabowska-Derlatka L, Koperski L, Królicki L.
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2273-80. PubMed ID: 25027709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard.
    Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS.
    Abdom Radiol (NY); 2017 Feb; 42(2):577-584. PubMed ID: 27665482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E, Turgut B, Cakmakcilar A, Erturk SA.
    Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.
    Salamon J, Veldhoen S, Apostolova I, Bannas P, Yamamura J, Herrmann J, Friedrich RE, Adam G, Mautner VF, Derlin T.
    Eur Radiol; 2014 Feb; 24(2):405-12. PubMed ID: 24097302
    [Abstract] [Full Text] [Related]

  • 13. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
    Yamane T, Takaoka A, Kita M, Imai Y, Senda M.
    Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
    Herrmann K, Erkan M, Dobritz M, Schuster T, Siveke JT, Beer AJ, Wester HJ, Schmid RM, Friess H, Schwaiger M, Kleeff J, Buck AK.
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):846-51. PubMed ID: 22278320
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL, Zhang YX, Wu ZJ, Jia Q, Wei H, Gao ZR.
    Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.
    Nakajo M, Nakajo M, Kajiya Y, Jinguji M, Nishimata N, Shimaoka S, Nihara T, Aridome K, Tanaka S, Fukukura Y, Tani A, Koriyama C.
    Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1223-32. PubMed ID: 23653240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.